The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), with major manifestations as Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic intestinal inflammatory disorder with an unknown etiology which pathogensis involving multifactorial immune disorder characterized by chronic relapsing inflammation of the in...
Main Authors: | Tri Hapsoro Guno, Marcellus Simadibrata |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2017-12-01
|
Series: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
Subjects: | |
Online Access: | http://ina-jghe.com/journal/index.php/jghe/article/view/642/515 |
Similar Items
-
An Overview of Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Sumona Bhattacharya, et al.
Published: (2020-12-01) -
Inflammatory bowel disease in Bahrain: single-center experience
by: Abdulla M, et al.
Published: (2017-07-01) -
Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID)
by: Marjo J. E. Campmans-Kuijpers, et al.
Published: (2021-03-01) -
Are We Ready for Biosimilars in Gastroenterology?
by: Muhammad Ilham Abdul Hafidz, et al.
Published: (2017-12-01) -
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
by: Gabrielle Wark, et al.
Published: (2021-12-01)